Literature DB >> 28217887

Gastric antral vascular ectasia in systemic sclerosis: Where do we stand?

Hala El-Gendy1, Kyrillus S Shohdy1, Gehad G Maghraby1, Kerolos Abadeer2, Moustafa Mahmoud1.   

Abstract

Gastric antral vascular ectasia (GAVE) continues to be a challenge in both diagnosis and treatment. GAVE has a diverse group of associations and presumed causes, including cirrhosis, chronic renal failure and autoimmune connective tissue diseases. However, in most occasions, the management plan of GAVE itself is the same whatever the underlying disease by using Argon plasma coagulation (APC). Herein, we will discuss three cases of systemic sclerosis-associated GAVE presenting with either acute or chronic gastrointestinal bleeding showing variable responses to APC. Anemia and telangiectasia may be the first striking presentation of systemic sclerosis (SSc). Renal artery stenosis, aortic stenosis, widespread cutaneous and mucosal telangiectasia and hypertension seem to be associated with poor prognosis and should prompt rapid intervention and careful follow-up. Moreover, the hunt for molecular underpinnings of the broad array of vascular lesions in SSc has to include von Willebrand factor and endoglin. Eventually, we will review the recent alternatives that can be effective in SSc-GAVE, such as band ligation, hematopoietic stem cells transplantation and immunotherapy.
© 2017 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  argon therapy; cyclophosphamide; gastric antral vascular ectasia; systemic sclerosis; von Willebrand factor

Mesh:

Year:  2017        PMID: 28217887     DOI: 10.1111/1756-185X.13047

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  4 in total

1.  Risk of bleeding events among patients with systemic sclerosis and the general population in the UK: a large population-based cohort study.

Authors:  Alexander Michel; Antonio González-Pérez; María E Sáez; Luis A García Rodríguez
Journal:  Clin Rheumatol       Date:  2019-05-14       Impact factor: 2.980

2.  Radiofrequency ablation (RFA) vs. argon plasma coagulation (APC) for the management of gastric antral vascular ectasia (GAVE) in patients with and without cirrhosis: results from a retrospective analysis of a large cohort of patients treated at a single center.

Authors:  Paul St Romain; Amanda Boyd; Jiayin Zheng; Shein-Chung Chow; Rebecca Burbridge; Daniel Wild
Journal:  Endosc Int Open       Date:  2018-02-28

Review 3.  Predicting the Progression of Very Early Systemic Sclerosis: Current Insights.

Authors:  Chiara Bellocchi; Augustine Chung; Elizabeth R Volkmann
Journal:  Open Access Rheumatol       Date:  2022-09-15

4.  HSCT-GAVE as a Manifestation of Chronic Graft versus Host Disease: A Case Report and Review of the Existing Literature.

Authors:  Michael J Grant; Mitchell E Horwitz
Journal:  Case Rep Transplant       Date:  2018-03-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.